| scholarly article | Q13442814 |
| P50 | author | Alexandra Paul | Q47244392 |
| P2093 | author name string | Ann Hammarstedt | |
| Ulf Smith | |||
| Shahram Hedjazifar | |||
| John R Grünberg | |||
| Johannes Elvin | |||
| P2860 | cites work | Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions | Q21285128 |
| WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors | Q22008485 | ||
| BMP4 and BMP Antagonists Regulate Human White and Beige Adipogenesis | Q47757011 | ||
| Smad6 inhibits signalling by the TGF-β superfamily | Q48044158 | ||
| miR-450a-5p within rat adipose tissue exosome-like vesicles promotes adipogenic differentiation by targeting WISP2. | Q48270611 | ||
| CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β. | Q53404791 | ||
| Functional annotation of the human fat cell secretome | Q60057002 | ||
| [Br]eaking FAt | Q85746698 | ||
| Longitudinal muscle gene expression patterns associated with differential intramuscular fat in cattle | Q85951888 | ||
| Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors | Q24303560 | ||
| CCN proteins: A centralized communication network | Q24601168 | ||
| Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter | Q24620189 | ||
| Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice | Q24620943 | ||
| Mesenchymal stem cells and immunomodulation: current status and future prospects | Q26770191 | ||
| Wnt/β-Catenin Signaling and Disease | Q26823272 | ||
| Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets | Q28254386 | ||
| Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms | Q28392359 | ||
| A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism | Q28513195 | ||
| Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human | Q29617382 | ||
| Paracrine mechanisms in adult stem cell signaling and therapy | Q29620571 | ||
| Wnt Proteins | Q30420997 | ||
| Adipocyte turnover: relevance to human adipose tissue morphology | Q33556451 | ||
| Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. | Q33672543 | ||
| Transcriptional control of preadipocyte determination by Zfp423. | Q33753951 | ||
| Tracking adipogenesis during white adipose tissue development, expansion and regeneration | Q33824485 | ||
| The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. | Q34067767 | ||
| The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis | Q34112864 | ||
| Mesenchymal stromal cells: current understanding and clinical status | Q34234464 | ||
| Brown and beige fat: development, function and therapeutic potential | Q34375850 | ||
| Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. | Q34442874 | ||
| Increased adipogenesis of human adipose-derived stem cells on polycaprolactone fiber matrices | Q34566523 | ||
| Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. | Q35016478 | ||
| CCN5, a Novel Transcriptional Repressor of the Transforming Growth Factor β Signaling Pathway | Q35102072 | ||
| CCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis | Q35827652 | ||
| Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis | Q35863725 | ||
| Wnt Signaling Activation in Adipose Progenitors Promotes Insulin-Independent Muscle Glucose Uptake | Q35885256 | ||
| The WNT Inhibitor Dickkopf 1 and Bone Morphogenetic Protein 4 Rescue Adipogenesis in Hypertrophic Obesity in Humans | Q35902839 | ||
| Obesity-associated improvements in metabolic profile through expansion of adipose tissue | Q35945161 | ||
| CCN5/WISP-2: A micromanager of breast cancer progression | Q36010510 | ||
| Interplay between mesenchymal stem cells and lymphocytes: implications for immunotherapy and tissue regeneration | Q36375063 | ||
| CCN5 Expression in mammals. III. Early embryonic mouse development | Q36398262 | ||
| CCN5 expression in mammals : I. Embryonic and fetal tissues of mouse and human | Q36510931 | ||
| LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. | Q36567999 | ||
| WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4. | Q36616934 | ||
| Concise review: mesenchymal stem cells and translational medicine: emerging issues. | Q37056276 | ||
| Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk | Q37115260 | ||
| CTGF Mediates Smad-Dependent Transforming Growth Factor β Signaling To Regulate Mesenchymal Cell Proliferation during Palate Development | Q37122742 | ||
| Domain-and species-specific monoclonal antibodies recognize the Von Willebrand Factor-C domain of CCN5 | Q37203098 | ||
| Adipogenesis and WNT signalling | Q37325263 | ||
| Inflammation and impaired adipogenesis in hypertrophic obesity in man. | Q37557999 | ||
| Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistance | Q37668148 | ||
| Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective | Q37670371 | ||
| Cellular models for understanding adipogenesis, adipose dysfunction, and obesity | Q37761693 | ||
| Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. | Q37875244 | ||
| Distinction of white, beige and brown adipocytes derived from mesenchymal stem cells | Q38190952 | ||
| Wnt10b inhibits obesity in ob/ob and agouti mice. | Q38305325 | ||
| Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin | Q38408437 | ||
| Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives | Q38621551 | ||
| Emerging roles of CCN proteins in vascular development and pathology | Q38848476 | ||
| IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin | Q39022548 | ||
| Concise Review: Mending a Broken Heart: The Evolution of Biological Therapeutics. | Q39149000 | ||
| Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases | Q39356461 | ||
| Spectraplakin family proteins - cytoskeletal crosslinkers with versatile roles | Q39416143 | ||
| Therapeutic potential of mesenchymal stem cells for diabetes | Q39455373 | ||
| Activation of canonical wingless-type MMTV integration site family (Wnt) signaling in mature adipocytes increases beta-catenin levels and leads to cell dedifferentiation and insulin resistance | Q39735987 | ||
| CCN5, a secreted protein, localizes to the nucleus | Q39866007 | ||
| BMP4 Gene Therapy in Mature Mice Reduces BAT Activation but Protects from Obesity by Browning Subcutaneous Adipose Tissue | Q40097957 | ||
| Estrogen-induced genes, WISP-2 and pS2, respond divergently to protein kinase pathway | Q40638603 | ||
| Matricellular Protein CCN5 Reverses Established Cardiac Fibrosis | Q40766923 | ||
| WISP-2: a serum-inducible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells | Q40799940 | ||
| WISP-2 as a novel estrogen-responsive gene in human breast cancer cells | Q40861272 | ||
| The matricellular protein CCN5 regulates podosome function via interaction with integrin αvβ 3. | Q40904183 | ||
| The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. | Q41846475 | ||
| The Novel Secreted Adipokine WNT1-inducible Signaling Pathway Protein 2 (WISP2) Is a Mesenchymal Cell Activator of Canonical WNT. | Q41849781 | ||
| Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells | Q42148476 | ||
| Effect of Wnt-1 inducible signaling pathway protein-2 (WISP-2/CCN5), a downstream protein of Wnt signaling, on adipocyte differentiation | Q42804383 | ||
| Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis. | Q42831868 | ||
| CCN5 Expression in mammals. II. Adult rodent tissues | Q43088666 | ||
| CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis | Q44239357 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 309-318 | |
| P577 | publication date | 2017-12-15 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Journal of Cell Communication and Signaling | Q26841964 |
| P1476 | title | CCN5/WISP2 and metabolic diseases | |
| P478 | volume | 12 |
Search more.